To include your compound in the COVID-19 Resource Center, submit it here.

Ziagen abacavir: Phase III results; marketed

In a double-blind Phase III trial in 562 antiretroviral-naive HIV patients in North America, Australia,

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE